Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts
暂无分享,去创建一个
M. Leon | D. Baim | J. Popma | D. Cutlip | K. Ho | B. George | D. Wahr | R. Kuntz | Joel D Greenberg | Unsal Kaya | Joel Greenberg
[1] R. Waksman,et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. , 2002, Circulation.
[2] P. Fitzgerald,et al. Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial). , 2001, The American journal of cardiology.
[3] P. Cohn,et al. Direct coronary stenting without balloon or device pretreatment: Acute success and long‐term results , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[4] D. Antoniucci,et al. Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction. , 2001, American heart journal.
[5] M. Bell,et al. Immediate and late outcomes after direct stent implantation without balloon predilation. , 2000, Journal of the American College of Cardiology.
[6] E. Topol,et al. Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.
[7] G. Stone,et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. , 1999, Circulation.
[8] W. O’Neill,et al. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. , 1999, Journal of the American College of Cardiology.
[9] W. Jordan,et al. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. , 1999, Cardiovascular surgery.
[10] David P Miller,et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block , 1998, Journal of the American College of Cardiology.
[11] D. Baim,et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.
[12] E. Topol,et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. , 1993, Journal of the American College of Cardiology.
[13] N L Geller,et al. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. , 1987, Biometrics.
[14] T. Ryan,et al. Transluminal Angioplasty in Experimental Atherosclerosis Analysis for Embolization Using an In Vivo Perfusion System , 1982, Circulation.